Clinical Trial Update: Canadian Active & Maintenance Modified Pentasa Study [Phase 3]

View source ↗

Summary

A Phase 3 Canadian trial evaluating active and maintenance therapy with Pentasa in Ulcerative Colitis has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Active Ulcerative Colitis, Remission of Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2016-04-22